---
$id: https://graph.org.ai/products/commodity/51152044
$type: Product
source: UNSPSC
code: "51152044"
title: "Silperisone"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Silperisone

**UNSPSC Code**: 51152044
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R16SK8726X. European Medicines Agency schedules Silperisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10521MIG. Silperisone generally arises in the molecular formula C15H24FNSI. The term SILPERISONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 no. 2 1999, list 40.) SILPERISONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule silperisone under HS 29333999 and SITC 51574. As of Q4 2014, SILPERISONE remains the US FDA Preferred Term for this commodity. Silperisone bears US NLM identifiers UMLS ID C1101150 and NCI Concept Code C74281. SMILES: [SI](CN1CCCCC1)(CC1CCC(F)CC1)(C)C.

